Germans Trias i Pujol Hospital

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse

Phase 4

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: methylprednisolone
Drug: Placebo

First Posted Date: 2008-09-17

Last Posted Date: 2011-06-02

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 49

Registration Number: NCT00753792

Locations: 🇪🇸
Hospital de Mataró, Barcelona, Spain
🇪🇸
Hospital Clinic de Barcelona, Barcelona, Spain
🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain

and more 4 locations

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Addition of raltegravir 800 mg QD to HAART

First Posted Date: 2008-07-18

Last Posted Date: 2019-12-05

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 15

Registration Number: NCT00718536

Locations: 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Salvage antiretroviral therapy including raltegravir

First Posted Date: 2008-05-28

Last Posted Date: 2019-12-04

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 15

Registration Number: NCT00685191

Locations: 🇪🇸
Hospital U. Germans Trias i Pujol, Badalona, Barcelona, Spain

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

Phase 4

Withdrawn

Conditions: HIV Infections

Interventions: Drug: Ibandronate
Behavioral: Lifestyle modifications

First Posted Date: 2008-04-21

Last Posted Date: 2019-03-13

Lead Sponsor: Germans Trias i Pujol Hospital

Registration Number: NCT00662077

Locations: 🇪🇸
Germans Trias i Pujol Hospital - Lluita Sida Foundation, Badalona, Barcelona, Spain

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

Phase 4

Terminated

Conditions: HIV Infections

Interventions: Drug: Nevirapine
Drug: Lopinavir/ritonavir

First Posted Date: 2008-04-18

Last Posted Date: 2019-12-05

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 9

Registration Number: NCT00661349

Locations: 🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸
Hospital Clínico de Salamanca, Salamanca, Spain
🇪🇸
Hospital Universitario Príncipe de Asturias, Madrid, Spain

and more 6 locations

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Darunavir 600mg + ritonavir 100mg twice day
Drug: Darunavir 900mg + ritonavir 100 mg once a day

First Posted Date: 2008-02-08

Last Posted Date: 2019-12-05

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 30

Registration Number: NCT00611039

Locations: 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain

Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: tipranavir/ritonavir (dose reduction)

First Posted Date: 2008-02-06

Last Posted Date: 2019-12-05

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 11

Registration Number: NCT00607958

Locations: 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain

Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression

Phase 3

Completed

Conditions: HIV Infections

Interventions: Drug: MK-0518 400mg twice a day

First Posted Date: 2007-11-06

Last Posted Date: 2019-12-04

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 69

Registration Number: NCT00554398

Locations: 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Hospital Clínic I Provinical de Barcelona, Barcelona, Spain

Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+

Phase 3

Completed

Conditions: HIV-1 Infection
Fibromyalgia

Interventions: Drug: Duloxetine 60 mg, QD

First Posted Date: 2007-11-02

Last Posted Date: 2019-12-04

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 10

Registration Number: NCT00552682

Locations: 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Phase 1

Completed

Conditions: Latent Tuberculosis Infection
Tuberculosis

Interventions: Biological: RUTI
Biological: placebo of the vaccine RUTI

First Posted Date: 2007-10-18

Last Posted Date: 2009-05-27

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 24

Registration Number: NCT00546273

Locations: 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Pharmacology Department. Hospital Universitari Germans Trias i Pujol., Badalona, Barcelona, Spain
🇪🇸
Experimental Tuberculosis Unit. Fundació Institut per la Investigació Germans Trias i Pujol, Badalona, Barcelona, Spain

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy